Please enable JavaScript to continue using this application.

Compare $BOLD vs $CLNN | Chartloom

Compare

$BOLD vs $CLNN

Boundless Bio Inc · Clene Inc

BOLD

Boundless Bio Inc

CLNN

Clene Inc

Compare $BOLD vs $CLNN

Comparing Boundless Bio Inc and Clene Inc

BOLDBoundless Bio Inc

CLNNClene Inc

BOLDBoundless Bio Inc

Market cap

$57M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

107.4%

52W performance

94.6%

FCF yield

-99.8%

CLNNClene Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

176.51x

Rev growth (TTM)

-31.1%

YTD performance

-33.1%

52W performance

-59.0%

FCF yield

-32.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BOLD

CLNN

Detailed metrics comparison

BOLD

Boundless Bio Inc

CLNN

Clene Inc

Market Cap

BOLD$57M

CLNN$49M

Enterprise Value

BOLD$37M

CLNN$58M

Price

BOLD$2.53

CLNN$3.86

P/E Ratio

BOLDN/A

CLNNN/A

P/S Ratio

BOLD0.00x

CLNN250.41x

EV/Sales

BOLD0.00x

CLNN296.36x

EV/EBITDA

BOLD0.00x

CLNN0.00x

P/B Ratio

BOLD0.90x

CLNN13.60x

P/FCF Ratio

BOLDN/A

CLNNN/A

EV/FCF

BOLD-0.65x

CLNN-3.66x

PEG Ratio

BOLDN/A

CLNNN/A

Forward P/E (NTM)

BOLDN/A

CLNNN/A

Forward P/S (NTM)

BOLDN/A

CLNN176.51x

Revenue (TTM)

BOLD$0

CLNN$197K

Revenue Growth (YoY)

BOLDN/A

CLNN-31.1%

Forward Rev Growth

BOLD0.0%

CLNN10485.4%

Gross Margin (TTM)

BOLD0.0%

CLNN70.1%

Operating Margin (TTM)

BOLD0.0%

CLNN0.0%

EBITDA Margin (TTM)

BOLD0.0%

CLNN-9704.6%

Net Margin (TTM)

BOLD0.0%

CLNN-20059.9%

FCF Margin (TTM)

BOLDN/A

CLNN-8094.9%

Net Income (TTM)

BOLD$-64M

CLNN$-40M

FCF (TTM)

BOLD$-57M

CLNN$-16M

EPS (TTM)

BOLD-$2.85

CLNN-$3.19

ROE (TTM)

BOLD-7089.0%

CLNN-32223.0%

ROA (TTM)

BOLD-4737.0%

CLNN-18564.0%

ROIC (TTM)

BOLD-7089.0%

CLNN-11721.0%

Cash

BOLD$20M

CLNN$10M

Debt

BOLD$0

CLNN$19M

Net Cash/Debt

BOLD$20M

CLNN$-9M

Current Ratio (TTM)

BOLD9.48x

CLNN3.07x

Quick Ratio (TTM)

BOLD9.35x

CLNN2.91x

Debt/Equity (TTM)

BOLD0.00x

CLNN6.36x

Debt/Assets (TTM)

BOLD0.0%

CLNN0.0%

Interest Coverage (TTM)

BOLDN/A

CLNNN/A

Net Debt/EBITDA (TTM)

BOLD0.00x

CLNN0.00x

Beta

BOLD0.44

CLNN1.06

52W Performance

BOLD94.6%

CLNN-59.0%

YTD Performance

BOLD107.4%

CLNN-33.1%

% from 52W High

BOLD-20.0%

CLNN-71.4%

% from 52W Low

BOLD163.2%

CLNN18.8%

Asset Turnover (TTM)

BOLD0.00x

CLNN0.01x

FCF Yield (TTM)

BOLD-99.8%

CLNN-32.3%

Earnings Yield (TTM)

BOLD-112.6%

CLNN-80.1%

Dividend Yield (TTM)

BOLDN/A

CLNNN/A

Rule of 40

BOLD0.0

CLNN-8,126.0

EV/GP/RG

BOLDN/A

CLNN10.10

Ticker research

View BOLD research View CLNN research

Metric	BOLD Boundless Bio Inc	CLNN Clene Inc
Market & Valuation
Market Cap	$57M	$49M
Enterprise Value	$37M	$58M
Price	$2.53	$3.86
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	250.41x
EV/Sales	0.00x	296.36x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	13.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.65x	-3.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	176.51x
Revenue & Growth
Revenue (TTM)	$0	$197K
Revenue Growth (YoY)	N/A	-31.1%
Forward Rev Growth	0.0%	10485.4%
Profitability
Gross Margin (TTM)	0.0%	70.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-9704.6%
Net Margin (TTM)	0.0%	-20059.9%
FCF Margin (TTM)	N/A	-8094.9%
Net Income (TTM)	$-64M	$-40M
FCF (TTM)	$-57M	$-16M
EPS (TTM)	-$2.85	-$3.19
ROE (TTM)	-7089.0%	-32223.0%
ROA (TTM)	-4737.0%	-18564.0%
ROIC (TTM)	-7089.0%	-11721.0%
Financial Health
Cash	$20M	$10M
Debt	$0	$19M
Net Cash/Debt	$20M	$-9M
Current Ratio (TTM)	9.48x	3.07x
Quick Ratio (TTM)	9.35x	2.91x
Debt/Equity (TTM)	0.00x	6.36x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.44	1.06
52W Performance	94.6%	-59.0%
YTD Performance	107.4%	-33.1%
% from 52W High	-20.0%	-71.4%
% from 52W Low	163.2%	18.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-99.8%	-32.3%
Earnings Yield (TTM)	-112.6%	-80.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-8,126.0
EV/GP/RG	N/A	10.10
Ticker research	View BOLD research	View CLNN research

Valuation

P/S Ratio

BOLD

0.00x

CLNN

250.41x

EV/FCF

CLNN

-3.66x

BOLD

-0.65x

Growth & revenue

Revenue Growth TTM

CLNN

-31.1%

Forward Revenue Growth

CLNN

10485.4%

BOLD

0.0%

Profitability & performance

Gross Margin

CLNN

70.1%

BOLD

0.0%

ROE

BOLD

-7089.0%

CLNN

-32223.0%

FCF Yield %

CLNN

-32.3%

BOLD

-99.8%

52-Week Performance

BOLD

94.6%

CLNN

-59.0%

Detailed metrics comparison

BOLD

Boundless Bio Inc

CLNN

Clene Inc

Market Cap

BOLD$57M

CLNN$49M

Enterprise Value

BOLD$37M

CLNN$58M

Price

BOLD$2.53

CLNN$3.86

P/E Ratio

BOLDN/A

CLNNN/A

P/S Ratio

BOLD0.00x

CLNN250.41x

EV/Sales

BOLD0.00x

CLNN296.36x

EV/EBITDA

BOLD0.00x

CLNN0.00x

P/B Ratio

BOLD0.90x

CLNN13.60x

P/FCF Ratio

BOLDN/A

CLNNN/A

EV/FCF

BOLD-0.65x

CLNN-3.66x

PEG Ratio

BOLDN/A

CLNNN/A

Forward P/E (NTM)

BOLDN/A

CLNNN/A

Forward P/S (NTM)

BOLDN/A

CLNN176.51x

Revenue (TTM)

BOLD$0

CLNN$197K

Revenue Growth (YoY)

BOLDN/A

CLNN-31.1%

Forward Rev Growth

BOLD0.0%

CLNN10485.4%

Gross Margin (TTM)

BOLD0.0%

CLNN70.1%

Operating Margin (TTM)

BOLD0.0%

CLNN0.0%

EBITDA Margin (TTM)

BOLD0.0%

CLNN-9704.6%

Net Margin (TTM)

BOLD0.0%

CLNN-20059.9%

FCF Margin (TTM)

BOLDN/A

CLNN-8094.9%

Net Income (TTM)

BOLD$-64M

CLNN$-40M

FCF (TTM)

BOLD$-57M

CLNN$-16M

EPS (TTM)

BOLD-$2.85

CLNN-$3.19

ROE (TTM)

BOLD-7089.0%

CLNN-32223.0%

ROA (TTM)

BOLD-4737.0%

CLNN-18564.0%

ROIC (TTM)

BOLD-7089.0%

CLNN-11721.0%

Cash

BOLD$20M

CLNN$10M

Debt

BOLD$0

CLNN$19M

Net Cash/Debt

BOLD$20M

CLNN$-9M

Current Ratio (TTM)

BOLD9.48x

CLNN3.07x

Quick Ratio (TTM)

BOLD9.35x

CLNN2.91x

Debt/Equity (TTM)

BOLD0.00x

CLNN6.36x

Debt/Assets (TTM)

BOLD0.0%

CLNN0.0%

Interest Coverage (TTM)

BOLDN/A

CLNNN/A

Net Debt/EBITDA (TTM)

BOLD0.00x

CLNN0.00x

Beta

BOLD0.44

CLNN1.06

52W Performance

BOLD94.6%

CLNN-59.0%

YTD Performance

BOLD107.4%

CLNN-33.1%

% from 52W High

BOLD-20.0%

CLNN-71.4%

% from 52W Low

BOLD163.2%

CLNN18.8%

Asset Turnover (TTM)

BOLD0.00x

CLNN0.01x

FCF Yield (TTM)

BOLD-99.8%

CLNN-32.3%

Earnings Yield (TTM)

BOLD-112.6%

CLNN-80.1%

Dividend Yield (TTM)

BOLDN/A

CLNNN/A

Rule of 40

BOLD0.0

CLNN-8,126.0

EV/GP/RG

BOLDN/A

CLNN10.10

Ticker research

View BOLD research View CLNN research

Metric	BOLD Boundless Bio Inc	CLNN Clene Inc
Market & Valuation
Market Cap	$57M	$49M
Enterprise Value	$37M	$58M
Price	$2.53	$3.86
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	250.41x
EV/Sales	0.00x	296.36x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	13.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.65x	-3.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	176.51x
Revenue & Growth
Revenue (TTM)	$0	$197K
Revenue Growth (YoY)	N/A	-31.1%
Forward Rev Growth	0.0%	10485.4%
Profitability
Gross Margin (TTM)	0.0%	70.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-9704.6%
Net Margin (TTM)	0.0%	-20059.9%
FCF Margin (TTM)	N/A	-8094.9%
Net Income (TTM)	$-64M	$-40M
FCF (TTM)	$-57M	$-16M
EPS (TTM)	-$2.85	-$3.19
ROE (TTM)	-7089.0%	-32223.0%
ROA (TTM)	-4737.0%	-18564.0%
ROIC (TTM)	-7089.0%	-11721.0%
Financial Health
Cash	$20M	$10M
Debt	$0	$19M
Net Cash/Debt	$20M	$-9M
Current Ratio (TTM)	9.48x	3.07x
Quick Ratio (TTM)	9.35x	2.91x
Debt/Equity (TTM)	0.00x	6.36x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.44	1.06
52W Performance	94.6%	-59.0%
YTD Performance	107.4%	-33.1%
% from 52W High	-20.0%	-71.4%
% from 52W Low	163.2%	18.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-99.8%	-32.3%
Earnings Yield (TTM)	-112.6%	-80.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-8,126.0
EV/GP/RG	N/A	10.10
Ticker research	View BOLD research	View CLNN research